Similar to NKG2D, sustained engagement of DNAM‐1 with PVR on tumor cells leads to downregulation of DNAM‐1 on the NK cell surface, potentially through receptor internalization followed by proteasomal degradation or by shedding of PVR from the tumor cell membrane into the extracellular environment. This evidence concerns the gene CD226 and neoplasm.